Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Decentralized Trials
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Decentralized Trials
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets
With a who’s who of drug developers going after BCMA, Amgen is stopping work on its bispecific contender for the multiple myeloma market.
Nick Paul Taylor
Aug 5, 2022 7:50am
Neurocrine axes essential tremor program on phase 2 data
Aug 5, 2022 4:53am
AstraZeneca quietly works on its own off-the-shelf CAR-Ts
Aug 4, 2022 6:00am
Fierce Biotech Fundraising Tracker: F2G, Sironax and more
Aug 4, 2022 4:20pm
Talis Bio walks away from COVID test plans, cuts 35% of staff
Aug 5, 2022 11:33am
Merck responds to FDA letter for chronic cough med gefapixant
Aug 5, 2022 10:21am
CRO News
Crown Bioscience rejigs executive team, plans global expansion
Aug 2, 2022 8:57am
Clario joins workplace diversity, equity and inclusion movement
Aug 2, 2022 8:00am
Labcorp to splice off clinical development arm
Jul 28, 2022 10:45am
Velocity Clinical Research buys trial site in Germany
Jul 27, 2022 3:45pm
See More CRO News